Innovative platform trial revolutionizes ALS research by testing multiple treatments simultaneously, offering new hope ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company pioneering a breakthrough non-invasive treatment approach for amyotrophic lateral sclerosis (ALS), is pleased to ...

Flack had been diagnosed with the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS), in 2022. Warwick took to X ...

The US singer was known for songs including Killing Me Softly With His Song and The First Time Ever I Saw Your Face.

Flack reached her breakthrough moment with "First Take" which she released in 1969 and included "The First Time Ever I Saw ...

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) da ...

Roberta Flack, the genre-blending R&B singer behind such hits as "Killing Me Softly With His Song," was selected to receive a ...

While previous research has suggested that a diet rich in omega-3 s could reduce the risk of developing MND and even extend ...

Singer Roberta Flack has died. Her team revealed her cause of death. Three years before she died, she shared her ALS ...

The Grammy Award-winning artist and educator had shared an ALS diagnosis in 2022. She was best known for ballads such as 'Killing Me Softly With His Song' and 'The First Time Ever I Saw Your Face.' ...

R&B vocalist Roberta Flack, best known for her chartbusters The First Time Ever I Saw Your Face and Killing Me Softly With ...

Dr. Bryant Lin, who teaches medicine at Stanford University, was given a terminal diagnosis. He wanted his students to ...